<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>The Doctors Lounge - Oncology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Doctors Lounge - Oncology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=The+Doctors+Lounge+-+Oncology&t=The+Doctors+Lounge+-+Oncology&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 10 Oct 2009 19:37:54 +0100</lastBuildDate>
        <item>
            <title>Thalidomide plus Topotecan better for ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=127962&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Foncology%2Farticles%2Fovary%2Fthalidomide_topotecan%2Findex.htm</link>
            <description>This trial is among the first to combine a biologic agent with a conventional chemotherapy agent for ovarian cancer. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=127962</comments>
            <pubDate>Mon, 31 Jul 2006 04:24:01 +0100</pubDate>
            <guid isPermaLink="false">127962</guid>        </item>
        <item>
            <title>St. Jude develops more affordable ALL follow-up test</title>
            <link>http://www.medworm.com/index.php?rid=127961&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Foncology%2Farticles%2Fleukemia%2Fminimal_residual%2Findex.htm</link>
            <description>A new test could give hospitals with limited resources an affordable way to improve the outcome of ALL treatment. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=127961</comments>
            <pubDate>Mon, 31 Jul 2006 04:24:01 +0100</pubDate>
            <guid isPermaLink="false">127961</guid>        </item>
        <item>
            <title>Study outlines therapy for breast cancer with BRCA mutation</title>
            <link>http://www.medworm.com/index.php?rid=127960&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Foncology%2Farticles%2Fbreast%2Fbrca_hormone%2Findex.htm</link>
            <description>Breast cancer with a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=127960</comments>
            <pubDate>Mon, 31 Jul 2006 04:24:01 +0100</pubDate>
            <guid isPermaLink="false">127960</guid>        </item>
        <item>
            <title>Breakthrough test clearly distinguishes Burkitt lymphoma from DLBCL</title>
            <link>http://www.medworm.com/index.php?rid=127959&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Foncology%2Farticles%2Flymphoma%2Fburkitt_gene_signature%2Findex.htm</link>
            <description>A gene expression signature clearly distinguishes Burkitt lymphoma from DLBCL, a critical distinction in diagnosis. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=127959</comments>
            <pubDate>Mon, 31 Jul 2006 04:24:01 +0100</pubDate>
            <guid isPermaLink="false">127959</guid>        </item>
        <item>
            <title>Tamoxifen for breast cancer prevention of little benefit</title>
            <link>http://www.medworm.com/index.php?rid=127958&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Foncology%2Farticles%2Fbreast%2Ftamoxifen_prevention%2Findex.htm</link>
            <description>Only women at very high risk for breast cancer experience a benefit according to a study published in the journal Cancer. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=127958</comments>
            <pubDate>Mon, 31 Jul 2006 04:24:01 +0100</pubDate>
            <guid isPermaLink="false">127958</guid>        </item>
        <item>
            <title>Breakthrough test clearly distinguishes Burkitt lymphoma from DLBCL</title>
            <link>http://www.medworm.com/index.php?rid=58786&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Flymphoma%2Fburkitt_gene_signature%2Findex.htm</link>
            <description>A gene expression signature clearly distinguishes Burkitt lymphoma from DLBCL, a critical distinction in diagnosis. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=58786</comments>
            <pubDate>Mon, 12 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">58786</guid>        </item>
        <item>
            <title>Study outlines therapy for breast cancer with BRCA mutation</title>
            <link>http://www.medworm.com/index.php?rid=56370&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fbreast%2Fbrca_hormone%2Findex.htm</link>
            <description>Breast cancer with a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=56370</comments>
            <pubDate>Fri, 09 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">56370</guid>        </item>
        <item>
            <title>Gene affects tamoxifen's benefit for breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=1209&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fbreast%2Ftamoxifen_gene%2Findex.htm</link>
            <description>Women with genetic variant that are taking tamoxifen were more likely to see their cancer return. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1209</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">1209</guid>        </item>
        <item>
            <title>Intraperitoneal chemotherapy superior for advanced ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=1208&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fovary%2Fintraperitoneal%2Findex.htm</link>
            <description>A study featured in Gynecologic Oncology shows the superiority of intraperitoneal chemotherapy in advanced ovarian cancer. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1208</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">1208</guid>        </item>
        <item>
            <title>Ultraviolet B light exposure increases risk of skin cancer</title>
            <link>http://www.medworm.com/index.php?rid=1207&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fskin%2Frisk_ultraviolet_B%2Findex.htm</link>
            <description>Inability to repair chromosomal damage caused by UV-B radiation increases risk of basal cell and squamous cell carcinomas. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1207</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">1207</guid>        </item>
        <item>
            <title>Thalidomide plus Topotecan better for ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=1206&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fovary%2Fthalidomide_topotecan%2Findex.htm</link>
            <description>This trial is among the first to combine a biologic agent with a conventional chemotherapy agent for ovarian cancer. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1206</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">1206</guid>        </item>
        <item>
            <title>St. Jude develops more affordable ALL follow-up test</title>
            <link>http://www.medworm.com/index.php?rid=1205&amp;cid=s_31141_6_f&amp;fid=31141&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Foncology%2Farticles%2Fleukemia%2Fminimal_residual%2Findex.htm</link>
            <description>A new test could give hospitals with limited resources an affordable way to improve the outcome of ALL treatment. (Source: The Doctors Lounge - Oncology)</description>
            <author>The Doctors Lounge - Oncology</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1205</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">1205</guid>        </item>
    </channel>
</rss>
